Start-Ups Swimming ...
Health Care: Drugs
Amgen Inc (AMGN: NASDAQ)
$105.59 -0.03 | -0.03%
05/24/13 - 01:10 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 105.62 |
| 52 Week High | 114.95 |
| 52 Week Low | 67.61 |
| Avg. Daily Vol. (Mil) | 4.23 |
| Beta (3 year) | 0.54 |
| Share Related Items | |
| Mkt Cap (Mil) | 79,212.52 |
| Shares Out (Mil) | 749.98 |
| Float (Mil) | 748.82 |
| Dividend Information | |
| Yield % | 1.80 |
| Annual Dividend | 1.88 |
| Payout Ratio | 26.00 |
| Financial Strength | |
| Quick Ratio | 4.60 |
| Current Ratio | 5.60 |
| LT Debt/ Equity | 1.23 |
| Total Debt / Equity | 1.23 |
| Valuation Ratios | |
| Price Earnings | 17.90 |
| Price/Sales | 4.54 |
| Price/Book | 4.06 |
| Price/Cash Flow | 9.70 |
| Per Share Data | |
| Earnings | 5.91 |
| Sales | 23.27 |
| Book Value | 25.99 |
| Cash Flow | 10.87 |
| Business Summary | |
|---|---|
| Amgen Inc. is a biotechnology medicines company. It discovers, develops, manufactures and delivers innovative human therapeutics. | |
| General Information | |
| One Amgen Center Drive
Thousand Oaks, CA 91320-1799 |
|
| www.Amgen.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 18000 | |
| CEO: Mr. Robert A. Bradway | |
| Short Interest | |
| Current Month (Mil) | 9.79 |
| Previous Month (Mil) | 10.62 |
| Short Interest Ratio (Days) | 2.10 |
| Management Effectiveness | |
| Return on Equity | 36.10 |
| Return on Assets | 13.60 |
| Return on Investments | 16.20 |
| Profitability | |
| Gross Margin | 88.00 |
| EBIT Margin | 33.80 |
| Profit Margin | 40.40 |
Portfolios with AMGN
- Portfolio NameUser Type
- ContributorTechnical Setups for the We...
- ContributorHigh Volume Technicals for ...
- UserDividend Stocks
- ContributorTechnical Setups for the We...
- ContributorTechnical Setups for the We...
- UserStevo
- ContributorPotential Dividend Hikes fo...
- UserMike Fatah's Mega Stock Por...
- UserGFNN Stockdiagnostics 23
- UserLong Term Stock Picks
Latest AMGN Headlines from TheStreet
- 5 Stocks Raising The Drugs Industry Higher 05.23.13 | 01:05 pm
- Amgen Inc (AMGN): Today's Featured Health Care Winner 05.21.13 | 05:05 pm
- AGN, LLY, BIIB, CELG And AMGN, Pushing Health Care Sector Downward 05.16.13 | 01:05 pm
- Amgen Inc (AMGN): Today's Featured Drugs Winner 05.14.13 | 05:05 pm
- 5 Stocks Going Ex-Dividend Tomorrow: HR, PMT, CNP, GG, AMGN 05.13.13 | 10:05 am
- Amgen Stock To Go Ex-dividend Tomorrow (AMGN) 05.13.13 | 09:05 am
- Amgen Inc (AMGN): Today's Featured Health Care Laggard 05.06.13 | 05:05 pm
- 5 Stocks Dragging In The Health Care Sector 05.06.13 | 01:05 pm
- All the Reasons in the World to Pull Back 05.04.13 | 06:05 am
- Analysts' Actions: AMGN BIIB DWA FCX ULTI 05.01.13 | 08:05 am
Press Releases for AMGN
- Amgen To Present At The Deutsche Bank 38th Annual Healthcare Conference - PR Newswire 05.23.13 | 05:05 pm
- Amgen Announces Voting Results Of Annual Meeting Of Stockholders - PR Newswire 05.22.13 | 05:05 pm
- Amgen To Present At The UBS Global Life Sciences Conference - PR Newswire 05.16.13 | 04:05 pm
- Amgen Highlights Data To Be Presented At American Society Of Clinical Oncology Annual Meeting - PR Newswire 05.15.13 | 06:05 pm
- Amgen And Zhejiang Beta Pharma Announce Planned Joint Venture In China - PR Newswire 05.09.13 | 04:05 pm
- Four Californians Selected As Breakaway From Cancer® Champions To Be Honored During Amgen Tour Of California - PR Newswire 05.01.13 | 04:05 pm
- Amgen Announces Webcast Of 2013 First Quarter Financial Results - PR Newswire 04.18.13 | 04:04 pm
- Pharmaceutical Companies, Investor Coalition Develop Industry Standard-Setting Principles For Recoupment Policies Covering Major Compliance Failures - PR Newswire 04.04.13 | 08:04 am
- Amgen Announces Top-Line Results Of Phase 3 Talimogene Laherparepvec Trial In Melanoma - PR Newswire 03.19.13 | 06:03 pm
- Amgen Announces 2013 Second Quarter Dividend - PR Newswire 03.06.13 | 04:03 pm
Partner Headlines for AMGN
- Big Cap Leaders Slide But Show Little Technical Damage - Investor's Business Daily 04.15.13 | 07:04 pm
- Pockets of Strength In Top Groups, Few Leaders Basing - Investor's Business Daily 04.15.13 | 06:04 pm
- Stocks End With Mild Losses; Nasdaq Rises 2.8% For Week - Investor's Business Daily 04.12.13 | 05:04 pm
- Can New Psoriasis Drugs Scratch Investors' Itch? - Investor's Business Daily 04.04.13 | 01:04 pm
- Cree, Seagate, Sandisk: Why Richie Freeman Likes Them - Investor's Business Daily 04.02.13 | 06:04 pm
- Biotech Breakout Boosting ETFs - Benzinga 03.28.13 | 03:03 pm
- Wall St rises as Fed reaffirms policies - Financial Times 03.20.13 | 08:03 pm
- Celgene Leads Handful Of Big Cap Stocks To New Highs - Investor's Business Daily 03.11.13 | 06:03 pm
- When To Add A New Full Position In A Good Stock - Investor's Business Daily 03.11.13 | 06:03 pm
- PDL BioPharma, Inc. (PDLI) Ex-Dividend Date Scheduled for March 01, 2013 - NASDAQ 02.27.13 | 02:02 pm
